Cormorant Asset Management, LP Sangamo Therapeutics, Inc Transaction History

Cormorant Asset Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$7.72 - $12.81 $1.5 Million - $2.49 Million	-194,274 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $54,454 - $95,051	-5,726 Reduced 2.86%	194,274 $2.23 Million
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $2.38 Million - $3.47 Million	-182,192 Reduced 47.67%	200,000 $3.39 Million
Q1 2018 May 15, 2018	SELL	$16.7 - $26.35 $297,393 - $469,240	-17,808 Reduced 4.45%	382,192 $7.26 Million
Q3 2017 Nov 14, 2017	BUY	$8.4 - $15.0 $3.36 Million - $6 Million	400,000	400,000 $6 Million

111

56.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $177M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.